Outpatient management of patients with cancer-associated pulmonary embolism (PE) may be a feasible, safe approach with low short-term rates of recurrent venous thromboembolism (VTE), major bleeding, ...

ResMed Inc . (NYSE:RMD; ASX:RMD), a leading player in the sleep and respiratory care market, has demonstrated strong operational performance in recent quarters. However, the company faces potential ...

"If you speak with women who have had previous heart attacks, they will often tell you that they had spoken with their doctor ...

GFS Advisors LLC raised its stake in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 2.7% in the 4th quarter, ...

They are also at greater risk for other heart, brain and cognitive issues  TORONTO, Feb. 4, 2025  According to a new report ...

ResMed’s (ASX:RMD) half-year FY25 results reflect a company that is not only thriving in its core business but is also ...

These launches are positioned for multi-blockbuster status, thanks to their promise of fulfilling unmet needs, impacting ...

H.I.G. Capital ("H.I.G."), a leading global alternative investment firm with $67 billion of capital under management, is pleased to announce the sale of its portfolio company, Soleo Health ("Soleo" or ...

Air quality monitors powered by artificial intelligence (AI) are being deployed in Uganda's capital city in efforts to drive down pollution-related illnesses, especially among vulnerable populations.

Verona Pharma plc (NASDAQ:VRNA – Get Free Report)’s stock price traded up 5.3% on Monday . The company traded as high as $59.74 and last traded at $60.32. 939,785 shares changed hands during trading, ...

Cibc World Market Inc. lowered its position in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 3.0% during the fourth ...

Chronic respiratory diseases due to pollution are on the rise, but with the right strategies, you can protect yourself and ...